Utitlity Navigation

☰ Menu

Search ACGT Foundation.org

Main menu

Skip to content
  • Home
  • News
  • Publications
  • Press
  • Events
  • Videos
  • Blog
  • Our Role & Impact
    • Mission & History
    • Progress & Impact
    • ACGT 2017 Facts & Figures
    • Our Leadership
    • Charity Ratings
    • Financial Reports
    • Required Disclosures
  • Cell & Gene Therapy
    • What are Cancer Cell & Gene Therapies?
    • Clinical Trials
    • Patient Stories
    • Glossary of Terms
    • Organizations & Resources
    • Cell & Gene Therapy FAQ
  • Grants & Research
    • ACGT Fellows
    • Institutions Supporting Research
    • Research Grants
    • Grants FAQ
  • Give to ACGT
    • Ways to Support the Research
    • Donate Now
    • Honor a Loved One
    • Legacy Giving
    • Be a Fundraiser
    • Contact Us
    • Stay Informed

Alliance For Cancer Gene Therapy

Advancing molecular therapies for cancer

ACGT Newsletter

Stay Informed with Rearch: Sign Up for the ACGT Newsletter

Donate to ACGT

Banner Nav

Skip to content
  • Our Role & Impact
    • Mission & History
    • Progress & Impact
    • ACGT 2017 Facts & Figures
    • Our Leadership
    • Charity Ratings
    • Financial Reports
    • Required Disclosures
  • Cell & Gene Therapy
    • What are Cancer Cell & Gene Therapies?
    • Clinical Trials
    • Patient Stories
    • Glossary of Terms
    • Organizations & Resources
    • Cell & Gene Therapy FAQ
  • Grants & Research
    • ACGT Fellows
    • Institutions Supporting Research
    • Research Grants
    • Grants FAQ
  • Give to ACGT
    • Ways to Support the Research
    • Donate Now
    • Honor a Loved One
    • Legacy Giving
    • Be a Fundraiser
    • Contact Us
    • Stay Informed

Bread Crumbs Navigation

Home / News / Funding Cutting-Edge Cell and Gene Therapy Research for Cancer

Funding Cutting-Edge Cell and Gene Therapy Research for Cancer

March 7, 2013

2012 Young Investigator Grant Recipients Announced

Dr. Alexander Stegh, Northwestern University and Dr. Douglas Mahoney, University of Calgary, Canada. Stegh’s research is focused on Glioblastoma. Mahoney’s, ACGT’s first International grant recipient, research is on Oncolytic Virus Therapy.

Read the press release.

Return to News

Footer Utility Navigation

Our Role & Impact

  • Mission & History
  • Progress & Impact
  • Our Leadership
  • Charity Ratings
  • Financial Reports

Cell & Gene Therapy

  • What are Cancer Cell and Gene Therapies?
  • Clinical Trials
  • Patient Stories
  • Glossary of Terms
  • Organizations & Resources
  • Cell & Gene Therapy FAQ

Grants & Research

  • ACGT Fellows
  • Institutions Supporting Research
  • Research Grants
  • Grants FAQ

Give to ACGT

  • Donate Now
  • Ways to Support Research
  • Honor a Loved One
  • Be a Fundraiser
  • Contact Us
  • Stay Informed

Connect With Us

  • Home
  • News
  • Press
  • Events
  • Videos
  • Publications
  • Blog
  • Contact Us

Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

ACGT Badges and Affiliates

ALLIANCE FOR CANCER GENE THERAPY® | 96 Cummings Point Road Stamford, CT, 06902 | 203.358.5055

©2026 All rights reserved by ACGT. ACGT is a 501(c)(3) organization and all contributions are tax-deductible under the law of your state.

  • Privacy Policy
ACGT scientists are successfully treating cancer with cell & gene therapy.

Learn more about exciting progress in targeted cancer therapies

SUBSCRIBE
for updates & events